Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Overview of Exosomes01:36

Overview of Exosomes

2.7K
Exosomes are stable, lipid bilayer-enclosed vesicles capable of crossing biological barriers. They can carry a wide range of molecules required for intercellular communication. Once exosomes are released from the cell where they originated, they enter a recipient cell through various pathways such as fusion, receptor-mediated endocytosis, macropinocytosis, and phagocytosis.
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
2.7K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Born under pressure: cardiac adaptation in congenital diaphragmatic hernia.

Pediatric research·2026
Same author

Targeted use of Prostaglandin E1 Therapy in "Duct-dependent" Congenital Diaphragmatic Hernia.

American journal of respiratory and critical care medicine·2026
Same author

Collecting Duct-Targeted Lipid Nanoparticles Deliver <i>Pkd2</i> mRNA to Restore Polycystin-2 and Attenuate ADPKD.

bioRxiv : the preprint server for biology·2026
Same author

Decorin promotes nascent proteoglycan retention in cartilage matrix by strengthening collagen II-aggrecan integration.

Acta biomaterialia·2026
Same author

When Air Is Not an Emergency: Using Intraperitoneal Sevoflurane to Rule Out Perforation.

Cureus·2026
Same author

Cognitive Decline in Atherosclerotic Diseases: Mechanisms and Potential Solutions.

CNS & neurological disorders drug targets·2026

相关实验视频

Updated: May 17, 2025

Evaluation of the Storage Stability of Extracellular Vesicles
11:31

Evaluation of the Storage Stability of Extracellular Vesicles

Published on: May 22, 2019

14.0K

开发治疗性增强的细胞外囊泡用于动脉样硬化治疗.

Neil Patel1, Elijah Avery1, Yi Huang1

  • 1Department of Biomedical Engineering, University of Southern California, Los Angeles, CA, USA.

Advanced healthcare materials
|April 7, 2025
PubMed
概括

装有microRNA-145 (miR-145) 的工程外细胞囊 (EVs) 有效地减少了小鼠的动脉样硬化斑块负担. 这些生物衍生纳米颗粒为治疗心血管疾病提供了合成载体的有希望的替代品.

关键词:
动脉样硬化 动脉样硬化细胞外囊泡中的细胞外囊泡.这是一个微型RNA.纳米药物是一种纳米药物.

更多相关视频

Optimizing Extracellular Vesicle Delivery Using a Core-Sheath 3D-Bioprinted Scaffold for Chronic Wound Management
09:23

Optimizing Extracellular Vesicle Delivery Using a Core-Sheath 3D-Bioprinted Scaffold for Chronic Wound Management

Published on: February 28, 2025

173
Isolation, Characterization, and Therapeutic Application of Extracellular Vesicles from Cultured Human Mesenchymal Stem Cells
07:03

Isolation, Characterization, and Therapeutic Application of Extracellular Vesicles from Cultured Human Mesenchymal Stem Cells

Published on: September 23, 2022

1.9K

相关实验视频

Last Updated: May 17, 2025

Evaluation of the Storage Stability of Extracellular Vesicles
11:31

Evaluation of the Storage Stability of Extracellular Vesicles

Published on: May 22, 2019

14.0K
Optimizing Extracellular Vesicle Delivery Using a Core-Sheath 3D-Bioprinted Scaffold for Chronic Wound Management
09:23

Optimizing Extracellular Vesicle Delivery Using a Core-Sheath 3D-Bioprinted Scaffold for Chronic Wound Management

Published on: February 28, 2025

173
Isolation, Characterization, and Therapeutic Application of Extracellular Vesicles from Cultured Human Mesenchymal Stem Cells
07:03

Isolation, Characterization, and Therapeutic Application of Extracellular Vesicles from Cultured Human Mesenchymal Stem Cells

Published on: September 23, 2022

1.9K

科学领域:

  • 心血管研究研究心血管研究
  • 纳米医学是一种纳米医学.
  • 分子生物学分子生物学

背景情况:

  • 动脉样硬化是全球主要的死亡原因,而他类药物治疗也有局限性.
  • 合成纳米颗粒用于药物输送,就像以前研究中用于microRNA-145 (miR-145) 的合成纳米颗粒一样,可以引起免疫反应,并且对慢性疾病的效率低.
  • 需要改进治疗策略,以减轻动脉样硬化的进展.

研究的目的:

  • 设计细胞外囊泡 (EVs) 作为一种生物衍生纳米粒子系统,用于输送miR-145以抑制动脉样硬化.
  • 为了增强对病原性血管光滑肌细胞 (VSMCs) 的EV向,使用单细胞化学吸引蛋白1 (MCP-1) .
  • 为了评估工程EVs的治疗疗效在体外和体内动脉样硬化模型.

主要方法:

  • 通过使用ExoMotifs加载miR-145并使用MCP-1功能化为向表达C-C化学受体的VSMC提供向输送的工程 EVs 2.
  • 在体外使用MCP-1-miR-145 EVs评估了VSMC基因表达和功能的恢复.
  • 与合成纳米颗粒相比,评估了用MCP-1-miR-145 EVs治疗的ApoE-/-动脉样硬化小鼠的斑块生长抑制.

主要成果:

  • 在体外,MCP-1-miR-145 EVs恢复了VSMC基因表达和功能.
  • 设计的电动汽车实现了与合成纳米颗粒类似的治疗效果,但其miR-145的剂量降低了25000倍.
  • 与合成纳米颗粒相比,MCP-1-miR-145 EVs在小鼠中显著抑制了斑块生长,而 miR-145的剂量比合成纳米颗粒低5000倍.

结论:

  • 充满miR-145的治疗性增强的细胞外囊泡代表了动脉样硬化治疗的强大和高效的输送系统.
  • 这种生物衍生的纳米粒子方法减轻了合成纳米粒子的缺点,提供了更好的安全性和有效性.
  • 基因工程电动汽车显示出显著的潜力,可以减少动脉样硬化斑块负担,并大幅降低治疗载荷.